<h4>Background</h4>Although numerous anticancer drugs targeting vascular endothelial growth factor (VEGF) are commonly used in clinical practice, life-threatening drug-drug interactions (DDIs) involving these drugs are rarely reported.<h4>Case summary</h4>A male patient had been taking aspirin for two years following a stroke. This evidence concerns the gene VEGFA and Stroke.